1. Home
  2. Labeler Index
  3. Novartis Pharmaceuticals Corporation
  4. 0078-0862
  5. Product Images: Durezol

Product Images Durezol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Durezol NDC 0078-0862 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Difluprednate structural formula - durezol 01

Difluprednate structural formula - durezol 01

Figure 1 Percent of Subjects With Anterior Chamber Cells Clearing (Cell Count = 0) - durezol 02

Figure 1 Percent of Subjects With Anterior Chamber Cells Clearing (Cell Count = 0) - durezol 02

This is a table showing the percentage of subjects with anterior chamber cells clearing on days 8 and 15. The data includes subjects who received Durezol QID or a placebo. The study involved 107 participants who received Durezol QID and 220 participants who received a placebo. The P-value was less than 0.05.*

Figure 2 Percent of Subjects Who Were Pain Free - durezol 03

Figure 2 Percent of Subjects Who Were Pain Free - durezol 03

This is a summary of a clinical trial where 107 subjects received Durezol and 220 subjects received placebo. The percentage of subjects who reported being pain-free was measured on Day 3, Day 8, and Day 15. The result indicates that the pain-free percentage for Durezol was statistically significant compared to the placebo.*

NDC 0078-0862-25 Rx Only DUREZOL® (difluprednate ophthalmic emulsion) 0.05% Sterile 5 mL NOVARTIS - durezol 04

NDC 0078-0862-25 Rx Only DUREZOL® (difluprednate ophthalmic emulsion) 0.05% Sterile 5 mL NOVARTIS - durezol 04

DUREZOL is an ophthalmic emulsion with difluprednate as an active ingredient used for treating eye problems. It comes in a 5mL bottle with a protective cap. The inactive ingredients include sodium chloride, edetate disodium, polysorbate 80, glycerin, and hydrochloric acid or sodium hydroxide to adjust pH. It should be stored between 2°C to 5°C and protected from light. The product should be kept in a cool and dry place. Proper dosage and usage instructions are printed on the package. The manufacturer is Novartis.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.